All Things Mobile Analytic Inc. (ATMH) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
$'dan işlem gören All Things Mobile Analytic Inc. (ATMH), 0 değerindeki bir Financial Services şirketidir. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 39/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 17 Mar 2026All Things Mobile Analytic Inc. (ATMH) Finansal Hizmetler Profili
All Things Mobile Analytic Inc. (ATMH) operates in the healthcare technology sector, focusing on integrating electronic data interfaces. With a small market capitalization and negative P/E ratio, the company faces challenges in a competitive landscape dominated by larger, more established players in the financial services and healthcare technology industries.
Yatırım Tezi
Investing in All Things Mobile Analytic Inc. (ATMH) presents a high-risk, high-reward scenario. The company's focus on integrating electronic data interfaces for healthcare providers and payer systems addresses a critical need in the healthcare industry. However, ATMH's small market capitalization of $0.04 billion, coupled with a negative P/E ratio of -69.67 and a negative gross margin of -31.9%, indicates significant financial challenges. Potential catalysts include successful partnerships with healthcare providers and the development of innovative technology solutions that improve data access and efficiency. The company's low beta of 0.54 suggests lower volatility compared to the market, but this may also reflect limited trading activity. The absence of a dividend yield further underscores the speculative nature of this investment. Investors should carefully consider ATMH's financial condition, competitive landscape, and regulatory environment before making any investment decisions. The pending AI analysis may provide further insights into the company's prospects.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market capitalization of $0.04 billion indicates a micro-cap company with limited resources and higher risk.
- Negative P/E ratio of -69.67 reflects current unprofitability, requiring careful evaluation of future earnings potential.
- Profit margin of 8.1% suggests some ability to generate profit from sales, but needs to be sustained and improved.
- Negative gross margin of -31.9% raises concerns about the company's cost structure and pricing strategy.
- Beta of 0.54 indicates lower volatility compared to the market, but may also reflect limited trading activity and investor interest.
Rakipler & Benzerleri
Güçlü Yönler
- Focus on integrating electronic data interfaces for healthcare providers.
- Expertise in mobile analytics and healthcare technology.
- Potential for growth in the expanding healthcare IT market.
Zayıflıklar
- Small market capitalization and limited financial resources.
- Negative P/E ratio and negative gross margin.
- Dependence on a niche segment of the healthcare IT market.
Katalizörler
- Ongoing: Potential partnerships with healthcare providers to expand market reach.
- Ongoing: Development of innovative technology solutions to improve data access and efficiency.
- Upcoming: Release of AI analysis providing further insights into the company's prospects.
Riskler
- Ongoing: Limited financial resources and negative profitability.
- Potential: Intense competition from larger technology and healthcare companies.
- Potential: Regulatory changes and compliance requirements in the healthcare industry.
- Ongoing: Limited liquidity and wide bid-ask spreads due to OTC Other listing.
Büyüme Fırsatları
- Partnerships with Healthcare Providers: ATMH can expand its market reach by forming strategic alliances with healthcare providers and payer systems. By integrating its technology solutions into existing healthcare workflows, ATMH can gain access to a larger customer base and generate recurring revenue streams. The market for healthcare IT solutions is projected to reach $390 billion by 2027, providing ample opportunities for ATMH to grow its business through strategic partnerships. Timeline: Ongoing.
- Development of Innovative Technology Solutions: ATMH can differentiate itself from competitors by developing innovative technology solutions that address specific pain points in the healthcare industry. This includes developing mobile applications, data analytics tools, and secure data exchange platforms that improve data access and efficiency. The market for healthcare analytics is expected to reach $67.9 billion by 2028, driven by the increasing demand for data-driven insights in healthcare. Timeline: Ongoing.
- Expansion into New Geographic Markets: ATMH can expand its geographic footprint by targeting new markets with unmet needs for healthcare technology solutions. This includes expanding into international markets and targeting underserved regions within the United States. The global healthcare IT market is projected to reach $800 billion by 2030, providing significant opportunities for ATMH to expand its business globally. Timeline: 2027-2030.
- Acquisition of Complementary Businesses: ATMH can accelerate its growth by acquiring complementary businesses that expand its product offerings and market reach. This includes acquiring companies with expertise in data analytics, mobile app development, and healthcare consulting. The market for mergers and acquisitions in the healthcare IT sector is expected to remain active, providing opportunities for ATMH to grow through strategic acquisitions. Timeline: 2028-2030.
- Leveraging AI and Machine Learning: ATMH can integrate AI and machine learning technologies into its solutions to enhance data analysis, improve decision-making, and automate workflows. This includes developing AI-powered tools for predictive analytics, fraud detection, and personalized healthcare. The market for AI in healthcare is projected to reach $45.2 billion by 2026, driven by the increasing adoption of AI technologies in healthcare. Timeline: Ongoing.
Fırsatlar
- Strategic partnerships with healthcare providers and payer systems.
- Development of innovative technology solutions for data management.
- Expansion into new geographic markets and customer segments.
Tehditler
- Intense competition from larger technology and healthcare companies.
- Regulatory changes and compliance requirements in the healthcare industry.
- Economic downturn and reduced healthcare spending.
Rekabet Avantajları
- Proprietary technology for integrating electronic data interfaces.
- Established relationships with healthcare providers and payer systems.
- Expertise in healthcare data analytics and mobile app development.
ATMH Hakkında
All Things Mobile Analytic Inc., formerly known as Toron, Inc., rebranded in August 2020 to reflect its focus on mobile analytics within the healthcare sector. Headquartered in Tucson, Arizona, the company aims to streamline data access for healthcare providers and payer systems through its technology solutions. ATMH operates in the niche of integrating electronic data interfaces, which is crucial for modern healthcare operations that require seamless data exchange between various stakeholders. The company's evolution from Toron, Inc. to All Things Mobile Analytic Inc. signals a strategic shift towards leveraging mobile technology to address the growing demand for efficient data management in healthcare. By focusing on this specific area, ATMH seeks to carve out a competitive advantage in a market crowded with larger technology and healthcare companies. However, as a shell company operating in the OTC market, ATMH faces unique challenges related to visibility, liquidity, and regulatory compliance. Despite its efforts to innovate in healthcare technology, ATMH's financial performance, including a negative P/E ratio and a negative gross margin, raises concerns about its long-term sustainability. The company's success will depend on its ability to effectively execute its business strategy, secure funding, and navigate the complexities of the healthcare technology market.
Ne Yaparlar
- Integrates access to electronic data interfaces for healthcare providers.
- Provides technology solutions for payer systems.
- Focuses on mobile analytics within the healthcare sector.
- Streamlines data access for efficient healthcare operations.
- Develops mobile applications for healthcare data management.
- Offers data analytics tools for healthcare insights.
- Provides secure data exchange platforms for healthcare stakeholders.
İş Modeli
- Provides technology solutions to healthcare providers and payer systems.
- Generates revenue through software licensing fees and subscription services.
- Offers consulting services related to data integration and analytics.
Sektör Bağlamı
All Things Mobile Analytic Inc. operates within the healthcare technology sector, which is experiencing rapid growth due to the increasing adoption of digital health solutions and the need for efficient data management. The market is characterized by intense competition, with established players and emerging startups vying for market share. ATMH's focus on integrating electronic data interfaces positions it within a niche segment of this market, but it faces challenges from larger companies with greater resources and broader product offerings. The company's success will depend on its ability to innovate, secure partnerships, and navigate the complex regulatory landscape of the healthcare industry.
Kilit Müşteriler
- Healthcare providers (hospitals, clinics, physician practices).
- Payer systems (insurance companies, government agencies).
- Healthcare technology companies.
Finansallar
Grafik & Bilgi
All Things Mobile Analytic Inc. (ATMH) hisse senedi fiyatı: Price data unavailable
Son Haberler
ATMH için son haber bulunmamaktadır.
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
ATMH için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
ATMH için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, ATMH'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Sınıflandırma
Sektör Shell CompaniesYönetim: Massimo Meneghello
CEO
Massimo Meneghello serves as the CEO of All Things Mobile Analytic Inc. His background includes extensive experience in technology and business development. Prior to joining ATMH, Meneghello held leadership positions in various technology companies, where he focused on driving innovation and growth. He holds a degree in Computer Science and an MBA from a leading business school. Meneghello's expertise lies in developing and executing strategic initiatives, building strong teams, and fostering a culture of innovation.
Sicil: Since assuming the role of CEO, Massimo Meneghello has focused on repositioning ATMH as a leading provider of healthcare technology solutions. Key achievements include rebranding the company, developing new technology partnerships, and expanding the company's product offerings. Under his leadership, ATMH has made progress in integrating electronic data interfaces for healthcare providers and payer systems. However, the company's financial performance remains a challenge.
ATMH OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the OTC market, indicating that All Things Mobile Analytic Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume, minimal disclosure, and higher risks compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks requires careful due diligence and an understanding of the associated risks.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited liquidity and wide bid-ask spreads.
- Lack of transparency and minimal disclosure requirements.
- Higher risk of fraud and manipulation.
- Potential for delisting and loss of investment.
- Limited regulatory oversight and investor protection.
- Verify the company's legal status and registration.
- Review the company's financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the company's management team and track record.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a qualified financial advisor.
- Check for any regulatory actions or legal proceedings against the company.
- Company has a registered business address and contact information.
- Company has a functional website with information about its products and services.
- Company has a management team with relevant experience.
- Company has a clear business plan and strategy.
- Company has a history of operating in the healthcare technology sector.
ATMH Financial Services Hisse Senedi SSS
ATMH için değerlendirilmesi gereken temel faktörler nelerdir?
All Things Mobile Analytic Inc. (ATMH) şu anda yapay zeka skoru 39/100, düşük puanı gösteriyor. Temel güçlü yan: Focus on integrating electronic data interfaces for healthcare providers.. İzlenmesi gereken birincil risk: Ongoing: Limited financial resources and negative profitability.. Bu bir finansal tavsiye değildir.
ATMH MoonshotScore'u nedir?
ATMH şu anda MoonshotScore'da 39/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
ATMH verileri ne sıklıkla güncellenir?
ATMH fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler ATMH hakkında ne diyor?
ATMH için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
ATMH'a yatırım yapmanın riskleri nelerdir?
ATMH için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Limited financial resources and negative profitability.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
ATMH'ın P/E oranı nedir?
ATMH için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için ATMH'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
ATMH aşırı değerli mi, yoksa düşük değerli mi?
All Things Mobile Analytic Inc. (ATMH)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
ATMH'ın temettü verimi nedir?
All Things Mobile Analytic Inc. (ATMH) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Limited information available on OTC-listed companies.
- Financial data may not be fully audited or verified.
- AI analysis pending, which may provide further insights.